Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia—Literature Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia—Literature Review
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 19, Pages 4377
Publisher
MDPI AG
Online
2021-09-27
DOI
10.3390/jcm10194377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations
- (2021) Sandeep Thakkar et al. CNS DRUGS
- Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
- (2021) Regina Katzenschlager et al. PARKINSONISM & RELATED DISORDERS
- Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease
- (2021) Robert A. Hauser et al. Frontiers in Neurology
- Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
- (2021) Bruna Meira et al. npj Parkinsons Disease
- Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation
- (2021) Tove Henriksen et al. Journal of Personalized Medicine
- Integrated transcriptome expression profiling reveals a novel lncRNA associated with L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease
- (2020) Chun-Lei Han et al. Aging-US
- The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
- (2020) Julia Castello et al. Scientific Reports
- EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease
- (2020) Caroline M. Tanner et al. Journal of Parkinsons Disease
- White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
- (2020) Seok Jong Chung et al. Annals of Clinical and Translational Neurology
- Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
- (2020) Bruno Lopes SANTOS-LOBATO et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- 6‐hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
- (2020) S. Vegas‐Suárez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine
- (2020) Weixing Shen et al. JOURNAL OF CLINICAL INVESTIGATION
- Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease
- (2020) Rhyomi C. Sellnow et al. JOURNAL OF NEUROSCIENCE
- Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single‐Photon Emission Computed Tomography Study
- (2020) Giovanni Palermo et al. MOVEMENT DISORDERS
- Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
- (2020) Changwei Yang et al. Frontiers in Aging Neuroscience
- Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders
- (2020) René A. J. Crans et al. Frontiers in Pharmacology
- µ opioid receptor agonism for L-DOPA-induced dyskinesia in Parkinson’s disease
- (2020) Erwan Bezard et al. JOURNAL OF NEUROSCIENCE
- Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding
- (2020) Mario Meloni et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats
- (2020) Alberto Brugnoli et al. NEUROBIOLOGY OF DISEASE
- Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia
- (2020) Valeria Calabrese et al. Frontiers in Aging Neuroscience
- Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease
- (2020) Ho-Sung Ryu et al. Frontiers in Neurology
- Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson’s disease
- (2020) Jin Yong Hong et al. PLoS One
- Dopamine D1 receptor signalling in dyskinetic Parkinsonian rats revealed by fiber photometry using FRET-based biosensors
- (2020) Jace Jones-Tabah et al. Scientific Reports
- Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
- (2020) Edward J. R. Fletcher et al. Frontiers in Neuroscience
- 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology
- (2020) Massimo E. Maffei INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
- (2020) Francesca Morgante et al. JOURNAL OF NEUROLOGY
- Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
- (2020) Ziqing Shi et al. Brain Sciences
- Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
- (2019) Rhyomi C. Sellnow et al. Acta Neuropathologica Communications
- Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis
- (2019) Yun Liu et al. Frontiers in Neurology
- Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study
- (2019) Leonardo Lopiano et al. JOURNAL OF NEUROLOGY
- Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
- (2019) Kathy Steece‐Collier et al. MOVEMENT DISORDERS
- Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies
- (2019) Enrica Olivola et al. NEUROLOGICAL SCIENCES
- Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety
- (2019) Werner Poewe et al. Journal of Parkinsons Disease
- Neurosteroids as regulators of neuroinflammation
- (2019) Canelif Yilmaz et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Role of striatal ΔFosB in l-Dopa–induced dyskinesias of parkinsonian nonhuman primates
- (2019) Goichi Beck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients
- (2019) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
- (2019) Albarrán-Bravo et al. Biomolecules
- The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia
- (2019) Yan Zhi et al. Aging-US
- Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients
- (2019) Maram Aljuaid et al. Frontiers in Neurology
- Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
- (2019) Han Soo Yoo et al. Annals of Clinical and Translational Neurology
- β-arrestin2 alleviates L-dopa–induced dyskinesia via lower D1R activity in Parkinson’s rats
- (2019) Xing-Ru Zhang et al. Aging-US
- Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats
- (2019) A. Aristieta et al. EXPERIMENTAL NEUROLOGY
- Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
- (2019) Paolo Calabresi et al. NEUROBIOLOGY OF DISEASE
- Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism
- (2019) Masatoshi Ogawa et al. Frontiers in Neurology
- Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia
- (2019) Shi‐Ying Fan et al. Annals of Clinical and Translational Neurology
- Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
- (2018) Ludovico Arcuri et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease
- (2018) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice
- (2018) Yi Liu et al. Journal of Neuroinflammation
- A Selective Phosphodiesterase 10A Inhibitor Reduces L -Dopa-Induced Dyskinesias in Parkinsonian Monkeys
- (2018) Goichi Beck et al. MOVEMENT DISORDERS
- A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia
- (2018) Allison E. Girasole et al. NEURON
- Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit
- (2018) Sakari Leino et al. NEUROPHARMACOLOGY
- Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates
- (2018) Arun Singh et al. Cell Reports
- Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia
- (2018) Michael B. Ryan et al. Cell Reports
- Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia
- (2018) Anton J.M. Loonen et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Diametric neural ensemble dynamics in parkinsonian and dyskinetic states
- (2018) Jones G. Parker et al. NATURE
- Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson’s disease
- (2018) Gourav R. Choudhury et al. PLoS One
- Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
- (2018) Irene Ruiz-DeDiego et al. Scientific Reports
- Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
- (2018) Ewa Papuć et al. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
- Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation
- (2018) Sakari Leino et al. BMC NEUROSCIENCE
- Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease
- (2018) M. Fabbri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia
- (2018) F. Gardoni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life
- (2018) Jean-François Houvenaghel et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Levodopa-induced dyskinesia in Parkinson disease
- (2018) Pierpaolo Turcano et al. NEUROLOGY
- Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
- (2018) Eun Hye Jeong et al. Frontiers in Neurology
- BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l -DOPA-induced dyskinesia in 6-OHDA-lesioned rats
- (2017) Elisabetta Tronci et al. EXPERIMENTAL NEUROLOGY
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
- (2017) Roberto Frau et al. EXPERIMENTAL NEUROLOGY
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia
- (2017) Andreas Dammann Andersen et al. JOURNAL OF NEUROCHEMISTRY
- CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors
- (2017) Marisol Cortés et al. JOURNAL OF NEUROSCIENCE
- Patient-driven N-of-1 in Parkinson’s Disease
- (2017) Kenton Unruh et al. METHODS OF INFORMATION IN MEDICINE
- Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice
- (2017) Xiomara A. Perez et al. MOVEMENT DISORDERS
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Dysregulation of BET proteins in levodopa-induced dyskinesia
- (2017) David A. Figge et al. NEUROBIOLOGY OF DISEASE
- Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
- (2017) Jennifer Stanic et al. NEUROBIOLOGY OF DISEASE
- Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum
- (2017) Stephanie L. Alberico et al. NEUROSCIENCE
- Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease
- (2017) Mario Meloni et al. PARKINSONISM & RELATED DISORDERS
- Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson’s Disease
- (2017) Satoshi Goto Frontiers in Cellular Neuroscience
- An updated meta-analysis of amantadine for treating dyskinesia in Parkinson’s disease
- (2017) Min Kong et al. Oncotarget
- Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
- (2017) Matthieu F. Bastide et al. Scientific Reports
- Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease
- (2017) Ying Wan et al. Frontiers in Aging Neuroscience
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
- (2017) Robert A. Hauser et al. Journal of Parkinsons Disease
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- Spine Enlargement of Pyramidal Tract-Type Neurons in the Motor Cortex of a Rat Model of Levodopa-Induced Dyskinesia
- (2017) Tatsuya Ueno et al. Frontiers in Neuroscience
- Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
- (2017) Joachim Brumberg et al. Annals of Clinical and Translational Neurology
- Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists
- (2016) Wei Xu et al. ACS Chemical Neuroscience
- The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
- (2016) C Miguelez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT 1A receptors
- (2016) A. Sagarduy et al. EXPERIMENTAL NEUROLOGY
- Structural and functional plasticity of dendritic spines - root or result of behavior?
- (2016) C. D. Gipson et al. GENES BRAIN AND BEHAVIOR
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
- (2016) Sophie Drapier et al. JOURNAL OF NEUROLOGY
- Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia
- (2016) David A. Figge et al. JOURNAL OF NEUROSCIENCE
- The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in L-DOPA-Induced Dyskinesia in Parkinsonian Rats
- (2016) D. Lindenbach et al. JOURNAL OF NEUROSCIENCE
- Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease
- (2016) Kristin B. Dupre et al. NEUROBIOLOGY OF DISEASE
- Motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study
- (2016) Leonardo Lopiano et al. NEUROLOGICAL SCIENCES
- Risk and course of motor complications in a population-based incident Parkinson's disease cohort
- (2016) Anders Bjornestad et al. PARKINSONISM & RELATED DISORDERS
- Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice
- (2016) Roberta Marongiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias
- (2016) Jennifer Stanic et al. Molecular Brain
- Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease
- (2015) Lisa F. Potts et al. ANNALS OF NEUROLOGY
- Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia
- (2015) Milica Cerovic et al. BIOLOGICAL PSYCHIATRY
- Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans
- (2015) Damian M. Herz et al. BRAIN
- Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys
- (2015) D. Gagnon et al. Brain Structure & Function
- Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling
- (2015) Oscar Solís et al. CEREBRAL CORTEX
- Overexpression of GRK6 rescues l-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats
- (2015) M. Rafiuddin Ahmed et al. EXPERIMENTAL NEUROLOGY
- Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
- (2015) Xiaoyu Li et al. Frontiers in Human Neuroscience
- The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
- (2015) O. Băjenaru et al. JOURNAL OF NEURAL TRANSMISSION
- Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat
- (2015) Nirmal Bhide et al. JOURNAL OF NEUROCHEMISTRY
- Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates
- (2015) Arun Singh et al. JOURNAL OF NEUROPHYSIOLOGY
- Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and L-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease
- (2015) C. B. Divito et al. JOURNAL OF NEUROSCIENCE
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia
- (2015) Sean Austin O. Lim et al. NEUROBIOLOGY OF DISEASE
- D3dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
- (2015) Doris E. Payer et al. NEUROLOGY
- M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
- (2015) Weixing Shen et al. NEURON
- Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia
- (2015) D. Lindenbach et al. NEUROSCIENCE
- Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
- (2015) Angelo Antonini et al. PARKINSONISM & RELATED DISORDERS
- Targeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease
- (2015) Nikhil M. Urs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unilateral subthalamic nucleus stimulation in the treatment of asymmetric parkinson's disease with early motor complications.
- (2015) Michał Sobstyl et al. Turkish Neurosurgery
- Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
- (2015) Ji Hee Kim et al. YONSEI MEDICAL JOURNAL
- The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
- (2015) Sven R Suwijn et al. EJNMMI Research
- Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases
- (2015) Zhen Ni et al. Translational Neurodegeneration
- The acute brain response to levodopa heralds dyskinesias in Parkinson disease
- (2014) Damian M. Herz et al. ANNALS OF NEUROLOGY
- Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats
- (2014) D Lindenbach et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
- (2014) Hiroya Utsumi et al. INTERNAL MEDICINE
- Motor Impairments, Striatal Degeneration, and Altered Dopamine-Glutamate Interplay in Mice Lacking PSD-95
- (2014) Jingping Zhang et al. JOURNAL OF NEUROGENETICS
- Inhibition of Adenylyl Cyclase Type 5 Prevents L-DOPA-Induced Dyskinesia in an Animal Model of Parkinson's Disease
- (2014) H.-Y. Park et al. JOURNAL OF NEUROSCIENCE
- Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5
- (2014) T. Fieblinger et al. JOURNAL OF NEUROSCIENCE
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson′s disease
- (2014) Jiancheng He et al. Neural Regeneration Research
- Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
- (2014) Sherri L. Thiele et al. NEUROBIOLOGY OF DISEASE
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
- (2014) Gurdal Sahin et al. PLoS One
- Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
- (2014) M. Heiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postsynaptic density protein 95-regulated NR2B tyrosine phosphorylation and interactions of Fyn with NR2B in levodopa-induced dyskinesia rat models
- (2014) Maowen Ba et al. Drug Design Development and Therapy
- L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
- (2014) Gregory Porras et al. Scientific Reports
- Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats
- (2014) Cheng-long Xie et al. Scientific Reports
- Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats
- (2014) SuFang Zhang et al. Scientific Reports
- Dopamine Signaling Leads to Loss of Polycomb Repression and Aberrant Gene Activation in Experimental Parkinsonism
- (2014) Erik Södersten et al. PLoS Genetics
- Modeling Parkinson's disease in monkeys for translational studies, a critical analysis
- (2013) Lisa F. Potts et al. EXPERIMENTAL NEUROLOGY
- The nicotine-mediated decline inl-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release
- (2013) Tanuja Bordia et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of dendritic calcium release in striatal spiny projection neurons
- (2013) Joshua L. Plotkin et al. JOURNAL OF NEUROPHYSIOLOGY
- Opiate Exposure and Withdrawal Induces a Molecular Memory Switch in the Basolateral Amygdala between ERK1/2 and CaMKII -Dependent Signaling Substrates
- (2013) D. Lyons et al. JOURNAL OF NEUROSCIENCE
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
- (2013) Elisabetta Tronci et al. NEUROBIOLOGY OF DISEASE
- Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice
- (2013) L. Li et al. NEUROSCIENCE
- Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/DeltaFosB expression
- (2013) Fernando Eduardo Padovan-Neto et al. NEUROSCIENCE LETTERS
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
- (2013) Hubert H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- The effects of BMY-14802 against l-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat
- (2013) Nirmal Bhide et al. PSYCHOPHARMACOLOGY
- Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
- (2013) Susanna Jakobson Mo et al. Biomed Research International
- Serotonin transporter inhibition attenuatesl-DOPA-induced dyskinesia without compromisingl-DOPA efficacy in hemi-parkinsonian rats
- (2012) Christopher Bishop et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dopamine- and cAMP-regulated Phosphoprotein of 32-kDa (DARPP-32)-dependent Activation of Extracellular Signal-regulated Kinase (ERK) and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Experimental Parkinsonism
- (2012) Emanuela Santini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
- (2012) Gregory Porras et al. JOURNAL OF CLINICAL INVESTIGATION
- L-DOPA Impairs Proteasome Activity in Parkinsonism through D1 Dopamine Receptor
- (2012) A. Berthet et al. JOURNAL OF NEUROSCIENCE
- G olf Mutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
- (2012) C. Alcacer et al. JOURNAL OF NEUROSCIENCE
- Levodopa-Induced Dyskinesia Is Strongly Associated with Resonant Cortical Oscillations
- (2012) P. Halje et al. JOURNAL OF NEUROSCIENCE
- Effect of Selective Serotonin Reuptake Inhibitors via 5-HT1A Receptors on L-DOPA-Induced Rotational Behavior in a Hemiparkinsonian Rat Model
- (2012) Masatoshi Inden et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Higher iron in the red nucleus marks Parkinson's dyskinesia
- (2012) Mechelle M. Lewis et al. NEUROBIOLOGY OF AGING
- Neuroinflammation and Synaptic Loss
- (2012) Jagadeesh S. Rao et al. NEUROCHEMICAL RESEARCH
- Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
- (2012) F. M. Weaver et al. NEUROLOGY
- The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats
- (2012) Asier Aristieta et al. PLoS One
- NMDA receptor genotypes associated with the vulnerability to develop dyskinesia
- (2012) S A Ivanova et al. Translational Psychiatry
- Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels
- (2011) Simone Bido et al. JOURNAL OF NEUROCHEMISTRY
- Serotonergic modulation of receptor occupancy in rats treated with l-DOPA after unilateral 6-OHDA lesioning
- (2011) Adjmal Nahimi et al. JOURNAL OF NEUROCHEMISTRY
- Behavioral and Cellular Modulation of L-DOPA-Induced Dyskinesia by -Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat
- (2011) D. Lindenbach et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task
- (2011) Antonio Cerasa et al. MOVEMENT DISORDERS
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
- (2011) Veronica Francardo et al. NEUROBIOLOGY OF DISEASE
- Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
- (2011) A. F. Ramlackhansingh et al. NEUROLOGY
- Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
- (2010) Daniella Rylander et al. ANNALS OF NEUROLOGY
- Microdialysis with Radiometric Monitoring of L-[β-11C]DOPA to Assess Dopaminergic Metabolism: Effect of Inhibitors of L-Amino Acid Decarboxylase, Monoamine Oxidase, and Catechol-O-Methyltransferase on Rat Striatal Dialysate
- (2010) Maki Okada et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons
- (2010) Masato Hara et al. JOURNAL OF NEUROCHEMISTRY
- Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
- (2010) S. Fasano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia
- (2009) A. Berthet et al. JOURNAL OF NEUROSCIENCE
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
- (2008) Naomi P. Visanji et al. NEUROBIOLOGY OF DISEASE
- l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
- (2007) Barbara Picconi et al. NEUROBIOLOGY OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started